Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway
Ovarian cancer is one of the most common causes of death from gynecologic tumors and is an important public health issue. Ghrelin is a recently discovered bioactive peptide that acts as a natural endogenous ligand of the growth hormone secretagogue receptor (GHSR). Several studies have identified th...
Main Authors: | R.X. Bai, W.P. Wang, P.W. Zhao, C.B. Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2016-03-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000300602&lng=en&tlng=en |
Similar Items
-
Expression of miR-409-3p in ovarian serous carcinoma and its effect on biological behaviors of HO-8910 cells
by: ZHU Jing, et al.
Published: (2020-11-01) -
Three-dimensional culture and clinical drug responses of a highly metastatic human ovarian cancer HO-8910PM cells in nanofibrous microenvironments of three hydrogel biomaterials
by: Hong Song, et al.
Published: (2020-06-01) -
Evaluation of the toxicity and repellence of an organic fatty acids mixture (C8910) against insecticide susceptible and resistant strains of the major malaria vector Anopheles funestus Giles (Diptera: Culicidae)
by: Michael Samuel, et al.
Published: (2015-06-01) -
Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
by: Yun Leng, et al.
Published: (2021-11-01) -
Ghrelin accelerates growth of olfactory ensheathing cells through ERK pathway
by: PEI ZHANG, et al.
Published: (2016-10-01)